Risk-prediction tools in prostate cancer: the challenge of tailoring

Por Morlacco, Alessandro, Pan, Jiahua, Karnes, R Jeffrey
Publicado no Asian J Androl (2016)

How to guide the selection of patients for trimodality therapy: the case for tumor immune and stromal signature

Por Boeri, Luca, Karnes, R. Jeffrey, Montanari, Emanuele
Publicado no Transl Androl Urol (2019)

A Noninvasive Multianalyte Urine-Based Diagnostic Assay for Urothelial Cancer of the Bladder in the Evaluation of Hematuria

Por Karnes, R. Jeffrey, Fernandez, Cecilia A., Shuber, Anthony P.
Publicado em 2012

Vitamins and Prostate Cancer Risk

Por Donkena, Krishna Vanaja, Karnes, R. Jeffrey, Young, Charles Y.F.
Publicado no Molecules (2010)

Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics

Por Moschini, Marco, Spahn, Martin, Mattei, Agostino, Cheville, John, Karnes, R. Jeffrey
Publicado no BMC Med (2016)

The Role of Radical Prostatectomy and Lymph Node Dissection in Clinically Node Positive Patients

Por Motterle, Giovanni, Ahmed, Mohamed E., Andrews, Jack R., Karnes, R. Jeffrey
Publicado no Front Oncol (2019)

What is the Need for Prostatic Biomarkers in Prostate Cancer Management?

Por Spahn, Martin, Boxler, Silvan, Joniau, Steven, Moschini, Marco, Tombal, Bertrand, Karnes, R. Jeffrey
Publicado no Curr Urol Rep (2015)

The Effects of Beginning Population Based PSA Screening at Age 40

Por Weight, Christopher J., Narayan, Vikram M., Smith, Daniel, Kim, Simon P., Karnes, R. Jeffrey
Publicado no Urology (2017)

Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort

Por Cooperberg, Matthew R., Davicioni, Elai, Crisan, Anamaria, Jenkins, Robert B., Ghadessi, Mercedeh, Karnes, R. Jeffrey
Publicado no Eur Urol (2014)

Vaginal cuff recurrence after radical cystectomy: an under - studied site of bladder cancer relapse

Por Zattoni, Fabio, Morlacco, Alessandro, Nehra, Avinash, Frank, Igor, Boorjian, Stephen A., Thapa, Prabin, Karnes, R. Jeffrey
Publicado no Int Braz J Urol (2018)

A noninvasive multi-analyte diagnostic assay: combining protein and DNA markers to stratify bladder cancer patients

Por Fernandez, Cecilia A, Millholland, John M, Zwarthoff, Ellen C, Feldman, Adam S, Karnes, R Jeffrey, Shuber, Anthony P
Publicado em 2012

LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer

Por Wang, Dejie, Ding, Liya, Wang, Liguo, Zhao, Yu, Sun, Zhifu, Karnes, R. Jeffrey, Zhang, Jun, Huang, Haojie
Publicado no Oncotarget (2015)

Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer

Por Zhao, Jingwen, Zhao, Yu, Wang, Liguo, Zhang, Jun, Karnes, R. Jeffrey, Kohli, Manish, Wang, Guixia, Huang, Haojie
Publicado no Oncotarget (2016)

Examining the association between adiposity and biochemical recurrence after radical prostatectomy

Por Mason, Ross J., Boorjian, Stephen A., Bhindi, Bimal, Rangel, Laureano, Frank, Igor, Karnes, R. Jeffrey, Tollefson, Matthew K.
Publicado no Can Urol Assoc J (2018)

Men (Aged 40–49 Years) With a Single Baseline Prostate-specific Antigen Below 1.0 ng/mL Have a Very Low Long-term Risk of Prostate Cancer: Results From a Prospectively Screened Pop...

Por Weight, Christopher J., Kim, Simon P., Jacobson, Debra J., McGree, Michaela E., Karnes, R. Jeffrey, St Sauver, Jennifer
Publicado em 2013

Quantitative Fluorescence in Situ Hybridization and its Ability to Predict Bladder Cancer Recurrence and Progression to Muscle-Invasive Bladder Cancer

Por Kipp, Benjamin R., Tanasescu, Mihaela, Else, Terry A., Bryant, Sandra C., Karnes, R. Jeffrey, Sebo, Thomas J., Halling, Kevin C.
Publicado em 2009

Endoscopic-Ultrasound-Guided Tissue Sampling Facilitates the Detection of Local Recurrence and Extra Pelvic Metastasis in Pelvic Urologic Malignancy

Por Gleeson, Ferga C., Clain, Jonathan E., Karnes, R. Jeffrey, Rajan, Elizabeth, Topazian, Mark D., Wang, Kenneth K., Levy, Michael J.
Publicado em 2012

Evaluation of Posttreatment Follow-Up of Patients With Prostate Cancer Relative to the American College of Radiology’s Appropriateness Criteria

Por McDonald, Jennifer S., Carter, Rickey E., Karnes, R. Jeffrey, Port, John D., Kawashima, Akira, Carlson, Stephanie K., Bender, Claire E.
Publicado no AJR Am J Roentgenol (2015)

AKT‐phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1‐MAPK interaction

Por Pan, Chun‐Wu, Jin, Xin, Zhao, Yu, Pan, Yunqian, Yang, Jing, Karnes, R Jeffrey, Zhang, Jun, Wang, Liguo, Huang, Haojie
Publicado no EMBO J (2017)

P300 acetyltransferase regulates fatty acid synthase expression, lipid metabolism and prostate cancer growth

Por Gang, Xiaokun, Yang, Yinhui, Zhong, Jian, Jiang, Kui, Pan, Yunqian, Karnes, R. Jeffrey, Zhang, Jun, Xu, Wanhai, Wang, Guixia, Huang, Haojie
Publicado no Oncotarget (2016)